Interleukin 1 receptor antagonist therapy-induced thrombocytopenia in adult onset Still's disease [7]

Journal of Rheumatology

Volumn 34, Issue 4, 2007, Pages 892-893

  Quartuccio, Luca ^a   De Vita, Salvatore ^a  

^a UNIVERSITY OF UDINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; PREDNISONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ADULT; ADULT ONSET STILL DISEASE; ARTHRITIS; CASE REPORT; CLINICAL FEATURE; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; FEVER; HUMAN; LETTER; MALE; PERICARDITIS; PLEURISY; PRIORITY JOURNAL; SIDE EFFECT; SORE THROAT; SPLENOMEGALY; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-1; STILL'S DISEASE, ADULT-ONSET; THROMBOCYTOPENIA;

EID: 34247324391     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (9)

1. Nuki G, Breshnihan B, Moraye BB, McCabe D. Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis. Arthritis Rheum 2002; 46:2838-46.
2. Cohen S, Hurd E, Cush J, et al. Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2002;46:614-24.
3. Cohen SB, Moreland LW, Cush JJ, et al. A multicenter, randomized, double-blind, placebo controlled trial of anakinra (Kineret) (a recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis treated with background methotrexate. Ann Rheum Dis 2004;63:1062-8.
4. Vasques Godinho FM, Parreira Santos MJ, Canas da Silva J. Refractory adult onset Still's disease successfully treated with anakinra. Ann Rheum Dis 2005;64:647-8.
5. Efthimiou P, Paik PK, Bielory L. Diagnosis and management of adult onset Still's disease. Ann Rheum Dis 2006;65:564-72.
6. Fautrel B, Zing E, Golmard JL, et al. Proposal for a new set of classification criteria for adult-onset Still's disease. Medicine (Baltimore) 2002;81:194-200.
7. den Broeder AA, de Jong E, Franssen MJAM, Jeurissen MEC, Flendrie M, van den Hoogen FHJ. Observational study on efficacy, safety, and drug survival of anakinra in rheumatoid arthritis patients in clinical practice. Ann Rheum Dis 2006;65:760-2.
8. van den Oudenrijn S, de Haas M, Calafat J, van der Schoot CE, von dem Borne AE. A combination of megakaryocyte growth and development factor and interleukin-1 is sufficient to culture large numbers of megakaryocyte progenitors and megakaryocytes for transfusion purposes. Br J Haematol 1999;106:553-63.
9. Pathare SK, Heycock C, Hamilton J. TNF-alpha blocker-induced thrombocytopenia. Rheumatology Oxford 2006;45:1313-4.